Pharmacology · Endocrine Pharmacology

A 32-year-old woman presents with amenorrhea, galactorrhea, and a serum prolactin of 180 ng/mL. MRI reveals a 6 mm pituitary microadenoma. The preferred drug for treatment is:

  • A Cabergoline
  • B Bromocriptine
  • C Octreotide
  • D Leuprolide
Correct answer: A. Cabergoline

Explanation

Cabergoline is a dopamine agonist and is the preferred treatment for prolactinoma because of superior efficacy, better tolerability, and twice-weekly dosing compared to bromocriptine. Both drugs reduce prolactin secretion and shrink tumor size. Octreotide is used for acromegaly. Leuprolide is a GnRH agonist used for prostate cancer and precocious puberty.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Endocrine Pharmacology MCQs

See all Endocrine Pharmacology MCQs →